Company intelligence / Profile preview

StriderDCT

Ownership: Private
Development stage: Other

Overview

StriderDCT is an active private company specializing in decentralized and hybrid digital clinical trial solutions. They focus on patient-centric, tech-enabled research models that streamline data collection and improve efficiency. Their platform features real-time analytics and offline eSource capabilities to enhance data integrity and accelerate insights throughout the trial lifecycle. The company has achieved ISO 9001:2015 certification for its quality management in clinical trial services[2]. No proprietary drug pipeline or direct therapeutic results are reported, as their business is enabling research rather than developing therapies[1][2].

Industry: Contract Research Organization

Beyond the preview

Go deeper on StriderDCT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on StriderDCT.

Explore the full profile